glp-1 craze GLP-1s are the current in health and wellness media, and elite athletes have even begun endorsing them. Registered dietician Eden Morris shares what athletes should know about the potential effects of New GLP-1 Weight-Loss Drug Mimics

Two weeks of liraglutide administration (0.6 mg/d for 1 week, 1.2 mg/d for 1 week, then 1.8 mg/d subcutaneously) in patients with obesity significantly reduced Thromboxane A 2 -induced platelet aggregation from baseline (Cahill et al

Alter, M

However, sharp, sudden, or persistent pain is not normal and indicates a need to stop the exercise and potentially seek advice

doi: 10.3389/fmicb.2023.1088187 [DOI] [PMC free article] [PubMed] [Google Scholar] 136

[DOI] [PubMed] [Google Scholar] 62.Krajewski P.K., Zotowska A., Szepietowski J.C

This medication offers a new option for individuals struggling with obesity, particularly those who have not had success with lifestyle modifications alone